Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Catalyst Pharm Inc
(NQ:
CPRX
)
20.00
+0.12 (+0.60%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
547,948
Open
20.09
Bid (Size)
20.00 (1)
Ask (Size)
20.25 (11)
Prev. Close
19.88
Today's Range
19.93 - 20.23
52wk Range
11.78 - 21.66
Shares Outstanding
102,780,151
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Catalyst Pharmaceuticals to Participate in the BofA Securities CNS Therapeutics Virtual Conference 2024
October 01, 2024
From
Catalyst Pharmaceuticals, Inc.
Via
GlobeNewswire
Catalyst Pharmaceuticals Announces Sub-Licensee DyDo Pharma Received Approval to Commercialize FIRDAPSE® in Japan
September 24, 2024
From
Catalyst Pharmaceuticals, Inc.
Via
GlobeNewswire
Performance
YTD
+16.89%
+16.89%
1 Month
+1.32%
+1.32%
3 Month
+31.67%
+31.67%
6 Month
+32.28%
+32.28%
1 Year
+65.43%
+65.43%
More News
Read More
A Biotech Breakout Will Be Led By Small Caps
September 23, 2024
Via
Talk Markets
Topics
Artificial Intelligence
Economy
Exposures
Artificial Intelligence
Interest Rates
NASDAQ:CPRX is showing good growth, while it is not too expensive.
September 13, 2024
Via
Chartmill
Exploring the Growth Potential of NASDAQ:CPRX as It Nears a Breakout.
August 29, 2024
Via
Chartmill
The Latest Analyst Ratings For Catalyst Pharmaceuticals
August 12, 2024
Via
Benzinga
Why NASDAQ:CPRX Is a Standout High-Growth Stock in a Consolidation Phase.
September 19, 2024
Via
Chartmill
Keros Therapeutics Stock Meets 80-Plus RS Rating Benchmark
September 05, 2024
Via
Investor's Business Daily
Innovative Drugmaker Roivant Puts Up Really Healthy Sales Numbers
August 29, 2024
Via
Investor's Business Daily
Biohaven Stock Earns Relative Strength Rating Upgrade
August 21, 2024
Via
Investor's Business Daily
SpringWorks Therapeutics Stock Clears Key Benchmark, Hitting 80-Plus RS Rating
August 21, 2024
Via
Investor's Business Daily
Investors should take notice of NASDAQ:CPRX—it offers a great deal for the fundamentals it presents.
August 21, 2024
Via
Chartmill
A Closer Look at 7 Analyst Recommendations For Catalyst Pharmaceuticals
June 03, 2024
Via
Benzinga
NASDAQ:CPRX stands out as a growth opportunity that won't break the bank.
August 21, 2024
Via
Chartmill
Immunome Stock Sees RS Rating Jump To 91
August 20, 2024
Via
Investor's Business Daily
Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences
August 20, 2024
From
Catalyst Pharmaceuticals, Inc.
Via
GlobeNewswire
PTC Therapeutics Stock Earns RS Rating Upgrade To 83
August 19, 2024
Via
Investor's Business Daily
Top 3 Health Care Stocks That May Crash In August
August 14, 2024
Via
Benzinga
CPRX Stock Earnings: Catalyst Pharmaceuticals Beats EPS, Beats Revenue for Q2 2024
August 07, 2024
Via
InvestorPlace
Catalyst Pharmaceuticals Reports Strong Second Quarter 2024 Financial Results and Provides Corporate Update
August 07, 2024
From
Catalyst Pharmaceuticals, Inc.
Via
GlobeNewswire
Top 3 Health Care Stocks You May Want To Dump This Quarter
July 30, 2024
Via
Benzinga
Vir Biotechnology Stock Reaches 80-Plus RS Rating Benchmark
July 26, 2024
Via
Investor's Business Daily
Catalyst Pharmaceuticals Enters Into an Exclusive License, Supply and Commercialization Agreement with Kye Pharmaceuticals for AGAMREE® in Canada
July 24, 2024
From
Catalyst Pharmaceuticals, Inc.
Via
GlobeNewswire
Catalyst Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 7, 2024
July 22, 2024
From
Catalyst Pharmaceuticals, Inc.
Via
GlobeNewswire
Trading SMID Biotech Stocks In A Volatile Market
July 01, 2024
Via
Talk Markets
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.